Gilead Sciences (GILD) 107.45 $GILD
Biogen, Celgene In Buy Range; LinkedIn Coming Back
at Investor's Business Daily - Mon Aug 25, 5:43PM CDT
Biotech stocks are well represented in this week's Big Cap 20, while LinkedIn (LNKD) and Facebook (FB) are pacing a rebound in Internet stocks. The Medical-Biomedical/Biotech industry has erased slightly more than half its losses since falling...
Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 5:25PM CDT
The EMA accepted Cubist Pharmaceuticals' (CBST) MAA for its investigational antibiotic, ceftolozane/tazobactam.
Most active Nasdaq-traded stocks
AP - Mon Aug 25, 5:24PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Final Glance: Biotechnology companies
AP - Mon Aug 25, 5:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Why Some Low-Volume Breakouts Can Still Work
at Investor's Business Daily - Mon Aug 25, 5:16PM CDT
In whatever you do, sometimes conditions don't go according to plan. Rain or other bad weather can kill your plans for a weekend picnic or stop you from going out on a cross-country bike ride. In the CAN SLIM investing method, one key thing that IBD...
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Mon Aug 25, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%, closing above the 2000 level for the first time. After the close, Amazon (AMZN) announced...
More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Aug 25, 3:43PM CDT
Roche is looking to buy InterMune, sending shares of ITMN up over 35 percent on the day.
Stocks Higher With Biotechs Leading The Way
at Investor's Business Daily - Mon Aug 25, 3:34PM CDT
The stock market was moderately higher Monday, with the S&P 500 topping 2000 intraday for the first time. Biotechs led the way on the strength of a major takeover. The Nasdaq and Dow industrials rose 0.4% each; the S&P 500 gained 0.5%. Nasdaq volume...
3 Reasons Johnson & Johnson's Stock Could Fall
Sean Williams, The Motley Fool - Motley Fool - Mon Aug 25, 2:53PM CDT
Bet against healthcare conglomerate Johnson & Johnson and you're liable to get hurt. Sure, it sounds like a line right out of The Sopranos , but it's the truth if you've dared to short-sell Johnson & Johnson's stock over the past four...
Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs
at Investor's Business Daily - Mon Aug 25, 1:54PM CDT
Major averages held on to decent gains with a little over one hour remaining in Monday's session. After topping the 2000 level, the S&P 500 rallied 0.5%; the Dow Jones industrial average also gained 0.5% while the Nasdaq tacked on 0.3%. Nasdaq volume...
Main Indexes Slip From Highs; Biotechs Show Strength
at Investor's Business Daily - Mon Aug 25, 12:27PM CDT
Stocks backed off session highs Monday, but were still nicely higher in early afternoon trading. The S&P 500 and Dow Jones industrial average each rose 0.4%. while the Nasdaq added 0.2%. Gains for the S&P 500 and Nasdaq hit 0.7% intraday. Turnover...
One Factor Driving Gilead Sciences (GILD) Stock Up to a One-Year High Today
at The Street - Mon Aug 25, 10:15AM CDT
Gilead Sciences (GILD) stock hit a new 52-week high after news that Roche would purchase InterMune (ITMN).
Early Glance: Biotechnology companies
AP - Mon Aug 25, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stocks Move Higher Early; Gilead, Autohome, Tesla Rising
at Investor's Business Daily - Mon Aug 25, 9:35AM CDT
Stocks bolted higher out of the starting gate Monday. All three major indexes -- the Nasdaq, S&P 500 and Dow Jones industrial average -- clocked 0.6% gains in opening trade. Financials led the Dow, with JPMorgan (JPM) andAmerican Express (AXP) rising...
Gilead Sciences Shares Up 47.7% Since SmarTrend's Buy Recommendation (GILD)
Comtex SmarTrend(R) - Mon Aug 25, 9:09AM CDT
SmarTrend identified an Uptrend for Gilead Sciences (NASDAQ:GILD) on April 22nd, 2014 at $72.56. In approximately 4 months, Gilead Sciences has returned 47.70% as of today's recent price of $107.17.
OncoMed Pharmaceuticals (OMED) in Focus: Stock Rises 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 7:51AM CDT
OncoMed Pharmaceuticals, Inc. (OMED) was a big mover last session, as its shares rose over 5% on the day.
'Fast Money' Recap: Will Apple Shares Pull Back?
at The Street - Sat Aug 23, 4:00AM CDT
The trading panel discussed the company's all-time high and how to trade following Janet Yellen's Jackson Hole comments.
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:55PM CDT
Bristol-Myers (BMY) and partner Pfizer (PFE) announced that the FDA has cleared Eliquis for an additional indication.
Biogen, Celgene In Buy Range; LinkedIn Coming Back
at Investor's Business Daily - Mon Aug 25, 5:43PM CDT
Biotech stocks are well represented in this week's Big Cap 20, while LinkedIn (LNKD) and Facebook (FB) are pacing a rebound in Internet stocks. The Medical-Biomedical/Biotech industry has erased slightly more than half its losses since falling...
Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 5:25PM CDT
The EMA accepted Cubist Pharmaceuticals' (CBST) MAA for its investigational antibiotic, ceftolozane/tazobactam.
Most active Nasdaq-traded stocks
AP - Mon Aug 25, 5:24PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Final Glance: Biotechnology companies
AP - Mon Aug 25, 5:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Why Some Low-Volume Breakouts Can Still Work
at Investor's Business Daily - Mon Aug 25, 5:16PM CDT
In whatever you do, sometimes conditions don't go according to plan. Rain or other bad weather can kill your plans for a weekend picnic or stop you from going out on a cross-country bike ride. In the CAN SLIM investing method, one key thing that IBD...
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Mon Aug 25, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%, closing above the 2000 level for the first time. After the close, Amazon (AMZN) announced...
More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Aug 25, 3:43PM CDT
Roche is looking to buy InterMune, sending shares of ITMN up over 35 percent on the day.
Stocks Higher With Biotechs Leading The Way
at Investor's Business Daily - Mon Aug 25, 3:34PM CDT
The stock market was moderately higher Monday, with the S&P 500 topping 2000 intraday for the first time. Biotechs led the way on the strength of a major takeover. The Nasdaq and Dow industrials rose 0.4% each; the S&P 500 gained 0.5%. Nasdaq volume...
3 Reasons Johnson & Johnson's Stock Could Fall
Sean Williams, The Motley Fool - Motley Fool - Mon Aug 25, 2:53PM CDT
Bet against healthcare conglomerate Johnson & Johnson and you're liable to get hurt. Sure, it sounds like a line right out of The Sopranos , but it's the truth if you've dared to short-sell Johnson & Johnson's stock over the past four...
Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs
at Investor's Business Daily - Mon Aug 25, 1:54PM CDT
Major averages held on to decent gains with a little over one hour remaining in Monday's session. After topping the 2000 level, the S&P 500 rallied 0.5%; the Dow Jones industrial average also gained 0.5% while the Nasdaq tacked on 0.3%. Nasdaq volume...
Main Indexes Slip From Highs; Biotechs Show Strength
at Investor's Business Daily - Mon Aug 25, 12:27PM CDT
Stocks backed off session highs Monday, but were still nicely higher in early afternoon trading. The S&P 500 and Dow Jones industrial average each rose 0.4%. while the Nasdaq added 0.2%. Gains for the S&P 500 and Nasdaq hit 0.7% intraday. Turnover...
One Factor Driving Gilead Sciences (GILD) Stock Up to a One-Year High Today
at The Street - Mon Aug 25, 10:15AM CDT
Gilead Sciences (GILD) stock hit a new 52-week high after news that Roche would purchase InterMune (ITMN).
Early Glance: Biotechnology companies
AP - Mon Aug 25, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stocks Move Higher Early; Gilead, Autohome, Tesla Rising
at Investor's Business Daily - Mon Aug 25, 9:35AM CDT
Stocks bolted higher out of the starting gate Monday. All three major indexes -- the Nasdaq, S&P 500 and Dow Jones industrial average -- clocked 0.6% gains in opening trade. Financials led the Dow, with JPMorgan (JPM) andAmerican Express (AXP) rising...
Gilead Sciences Shares Up 47.7% Since SmarTrend's Buy Recommendation (GILD)
Comtex SmarTrend(R) - Mon Aug 25, 9:09AM CDT
SmarTrend identified an Uptrend for Gilead Sciences (NASDAQ:GILD) on April 22nd, 2014 at $72.56. In approximately 4 months, Gilead Sciences has returned 47.70% as of today's recent price of $107.17.
OncoMed Pharmaceuticals (OMED) in Focus: Stock Rises 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 7:51AM CDT
OncoMed Pharmaceuticals, Inc. (OMED) was a big mover last session, as its shares rose over 5% on the day.
'Fast Money' Recap: Will Apple Shares Pull Back?
at The Street - Sat Aug 23, 4:00AM CDT
The trading panel discussed the company's all-time high and how to trade following Janet Yellen's Jackson Hole comments.
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:55PM CDT
Bristol-Myers (BMY) and partner Pfizer (PFE) announced that the FDA has cleared Eliquis for an additional indication.
